BENITEC BIOPHARMA INC (BNTC)
US08205P2092 - Common Stock
| TTM (2024-9-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | N/A | -21.75M | N/A | N/A | N/A | |||
| Depreciation Amortization | N/A | 87.00K | N/A | N/A | N/A | |||
| Change In Working Capital | 5.85M | 1.17M | -18.01M | -15.90M | -12.83M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 1.43M | 1.09M | N/A | N/A | N/A | |||
| OPERATING CASH FLOW | -19.41M | -19.40M | -18.01M | -15.90M | -12.83M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -179.00K | 0.00 | -10.00K | -220.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | N/A | -179.00K | 0.00 | -10.00K | -220.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 64.69M | 73.92M | 17.88M | 0.00 | 25.75M | |||
| Other Financing Activity | -2.93M | -5.89M | -1.87M | 0.00 | -3.23M | |||
| FINANCING CASH FLOW | 61.77M | 68.03M | 16.02M | 0.00 | 22.52M | |||
| Exchange Rate Effect | -146.00K | -8.00K | 410.00K | 200.00K | 500.00K | |||
| CHANGE IN CASH | 42.03M | 48.44M | -1.58M | -15.71M | 9.97M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -19.41M | -19.40M | -18.01M | -15.90M | -12.83M | |||
| Capital Expenditure | N/A | -179.00K | 0.00 | -10.00K | -220.00K | |||
| FREE CASH FLOW | -19.59M | -19.58M | -18.01M | -15.91M | -13.05M | |||
All data in USD